Orion 

$45.90
148
+$0.13+0.28% Friday 18:44

Statistics

Day High
47.19
Day Low
46.94
52W High
47.19
52W Low
30.89
Volume
4
Avg. Volume
202
Mkt Cap
2.59B
P/E Ratio
18.16
Dividend Yield
2.16%
Dividend
0.99

Upcoming

Dividends

2.16%Dividend Yield
Apr 26
$0.52
Nov 25
$0.47
Apr 25
$0.46
Nov 24
$0.44
Apr 24
$0.44
10Y Growth
3%
5Y Growth
2.2%
3Y Growth
4.5%
1Y Growth
10.35%

Earnings

29OctExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q2 2026
Next
0.09
0.67
1.25
1.84
Expected EPS
0.0871396448
Actual EPS
N/A

Financials

-3.88%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.81BRevenue
-70.1MNet Income

Analyst Ratings

7.50Average Price Target
The highest estimate is 7.50.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ORINY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novo Nordisk
NVO
Mkt Cap201.64B
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This competes directly with Orion's pharmaceutical products, especially in the diabetes and hormone replacement sectors.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global pharmaceutical corporation which competes across various therapeutic areas including oncology, neurology, and immunology, overlapping with Orion's product portfolio.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. is known for its contributions to pharmaceuticals across a range of conditions, directly competing with Orion in areas like cancer and neurodegenerative diseases.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca operates in key areas such as oncology, cardiovascular, renal & metabolism, and respiratory & immunology, which are also focus areas for Orion, making them direct competitors.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline is a global healthcare company that researches and develops a broad range of innovative products in pharmaceuticals, vaccines, and consumer healthcare, competing with Orion especially in the respiratory and CNS sectors.
Rogers
ROG
Mkt Cap2.24B
Roche Holding AG is a pioneer in healthcare, leading in cancer treatments and diagnostics, directly competing with Orion's oncology and diagnostic products.
Novartis
NVS
Mkt Cap292.35B
Novartis is one of the largest pharmaceutical companies by both market cap and sales, competing in areas like oncology, neurology, and immunology, similar to Orion.
Sanofi
SNY
Mkt Cap107.39B
Sanofi focuses on pharmaceuticals and human vaccines, with a strong presence in diabetes, oncology, and rare diseases, areas that Orion also operates in.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries Ltd. is a global leader in generic and specialty medicines, competing with Orion in the provision of generic drugs and active pharmaceutical ingredients.

About

Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical, and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. The Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing, and special applications. Geographically, it derives a majority of its revenue from Germany.
Show more...
CEO
Corning F. Painter
Employees
1639
Country
Luxembourg
ISIN
US68628Y1047
WKN
000A14W01

Listings

0 Comments

Share your thoughts

FAQ

What is Orion stock price today?
The current price of ORINY is $45.90 USD — it has increased by +0.28% in the past 24 hours. Watch Orion stock price performance more closely on the chart.
What is Orion stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Orion stocks are traded under the ticker ORINY.
Is Orion stock price growing?
ORINY stock has fallen by -1.77% compared to the previous week, the month change is a +6.69% rise, over the last year Orion has showed a +17.68% increase.
What is Orion market cap?
Today Orion has the market capitalization of 2.59B
When is the next Orion earnings date?
Orion is going to release the next earnings report on October 29, 2026.
What were Orion earnings last quarter?
ORINY earnings for the last quarter are 0.14 USD per share, whereas the estimation was 0.16 USD resulting in a -13.18% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Orion revenue for the last year?
Orion revenue for the last year amounts to 1.81B USD.
What is Orion net income for the last year?
ORINY net income for the last year is -70.1M USD.
Does Orion pay dividends?
Yes, ORINY dividends are paid semi-annual. The last dividend per share was 0.52 USD. As of today, Dividend Yield (FWD)% is 2.16%.
How many employees does Orion have?
As of September 06, 2026, the company has 1,639 employees.
In which sector is Orion located?
Orion operates in the Materials sector.
When did Orion complete a stock split?
Orion has not had any recent stock splits.
Where is Orion headquartered?
Orion is headquartered in SPRING, Luxembourg.